These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22669478)

  • 1. Increase of 20-HETE synthase after brain ischemia in rats revealed by PET study with 11C-labeled 20-HETE synthase-specific inhibitor.
    Kawasaki T; Marumo T; Shirakami K; Mori T; Doi H; Suzuki M; Watanabe Y; Chaki S; Nakazato A; Ago Y; Hashimoto H; Matsuda T; Baba A; Onoe H
    J Cereb Blood Flow Metab; 2012 Sep; 32(9):1737-46. PubMed ID: 22669478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
    Liu Y; Li Y; Zhan M; Liu Y; Li Z; Li J; Cheng G; Teng G; Lu L
    Brain Res; 2019 Apr; 1708():160-170. PubMed ID: 30571981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
    Dunn KM; Renic M; Flasch AK; Harder DR; Falck J; Roman RJ
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2455-65. PubMed ID: 18952718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
    Zhang Y; Hoda MN; Zheng X; Li W; Luo P; Maddipati KR; Seki T; Ergul A; Wang MH
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R693-703. PubMed ID: 24990856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia.
    Poloyac SM; Zhang Y; Bies RR; Kochanek PM; Graham SH
    J Cereb Blood Flow Metab; 2006 Dec; 26(12):1551-61. PubMed ID: 16570075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.
    Chen YJ; Li J; Quilley J
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2305-12. PubMed ID: 18326808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
    Miyata N; Seki T; Tanaka Y; Omura T; Taniguchi K; Doi M; Bandou K; Kametani S; Sato M; Okuyama S; Cambj-Sapunar L; Harder DR; Roman RJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):77-85. PubMed ID: 15831442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel acetamidobenzoxazolone-based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain.
    Tiwari AK; Yui J; Fujinaga M; Kumata K; Shimoda Y; Yamasaki T; Xie L; Hatori A; Maeda J; Nengaki N; Zhang MR
    J Neurochem; 2014 May; 129(4):712-20. PubMed ID: 24484439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney.
    Poloyac SM; Tortorici MA; Przychodzin DI; Reynolds RB; Xie W; Frye RF; Zemaitis MA
    Drug Metab Dispos; 2004 Jul; 32(7):727-33. PubMed ID: 15205388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat.
    Schwartzman ML; da Silva JL; Lin F; Nishimura M; Abraham NG
    Nephron; 1996; 73(4):652-63. PubMed ID: 8856265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 20-HETE in the hypoxia-induced activation of Ca2+-activated K+ channel currents in rat cerebral arterial muscle cells.
    Gebremedhin D; Yamaura K; Harder DR
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H107-20. PubMed ID: 17906097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
    Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
    Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.
    Savas Ü; Wei S; Hsu MH; Falck JR; Guengerich FP; Capdevila JH; Johnson EF
    J Biol Chem; 2016 Aug; 291(32):16904-19. PubMed ID: 27298316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors.
    Nakamura T; Kakinuma H; Umemiya H; Amada H; Miyata N; Taniguchi K; Bando K; Sato M
    Bioorg Med Chem Lett; 2004 Jan; 14(2):333-6. PubMed ID: 14698153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex.
    Liu X; Li C; Falck JR; Roman RJ; Harder DR; Koehler RC
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H619-31. PubMed ID: 18502903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury.
    Muroya Y; Fan F; Regner KR; Falck JR; Garrett MR; Juncos LA; Roman RJ
    J Am Soc Nephrol; 2015 Oct; 26(10):2460-9. PubMed ID: 25644108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.
    Kawamura M; Kobashi Y; Tanaka H; Bohno-Mikami A; Hamada M; Ito Y; Hirata T; Ohara H; Kojima N; Koretsune H; Gunji E; Fukunaga T; Inatani S; Hasegawa Y; Suzuki A; Takahashi T; Kakinuma H
    J Med Chem; 2022 Nov; 65(21):14599-14613. PubMed ID: 36318660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
    Alonso-Galicia M; Maier KG; Greene AS; Cowley AW; Roman RJ
    Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways.
    Bao Y; Wang X; Li W; Huo D; Shen X; Han Y; Tan J; Zeng Q; Sun C
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):294-301. PubMed ID: 21266918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and quantitative analysis of hydroxy-eicosatetraenoic acids in rat brains exposed to regional ischemia.
    Usui M; Asano T; Takakura K
    Stroke; 1987; 18(2):490-4. PubMed ID: 3564108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.